“…Combining the guanylhydrazone pharmacophore, which is known to be a S-adenosylmethionine decarboxylase inhibitor and a trypanocidal motif by itself, with lipophilically substituted adamantane moieties, a synergistic effect of lipophilicity at C1 of the adamantane scaffold and the C2 functionality could be observed in compounds 195 , 359
199 , and 200 . 360 For this class of trypanocides, a decane- (or “oxadecane” substitution, for that matter) substituent at C1 was shown to be ideal in terms of in vitro trypanocidal potency. Lastly, oxaheterocyclic amines like oxaadamantane 198 361 and the secondary amine 201 362 have also been shown to display anti- T. brucei activity in vitro ; furthermore, the latter oxapolycyclic amine is devoid of any NMDA-receptor antagonism, which could be useful to avoid CNS-related side effects when using these compounds to combat T. brucei and other trypanosomes clinically.…”